| Date | Title | Description |
| 13.08.2026 | Myasthenia Gravis Relapse After Surgery Finally Explained by 347,000-Cell Atlas | By Joseph Blake
Published: Aug 13 2026, 10:11 AM EDT
Share on Facebook Share on Twitter Share on LinkedIn Share on Reddit Share on Flipboard |
| 06.08.2026 | Deep Brain Stimulation Activates Hidden Astrocyte Gene Programs in Human Tissue Study | By Otis D. Sheehan
Published: Aug 06 2026, 2:47 PM EDT
Share on Facebook Share on Twitter Share on LinkedIn Share on Reddit Share on Flipboard |
| 07.07.2026 | Migraine Doubles Restless Legs Risk: Screen Patients Before Prescribing Either Treatment | By Maxwell Templeton
Published: Jul 07 2026, 3:45 PM EDT
Share on Facebook Share on Twitter Share on LinkedIn Share on Reddit Share on Flipboard |
| 24.06.2026 | Colorado’s proposed SNAP ‘soda ban’ likely dead after judge’s ruling | Getting your Trinity Audio player ready...
Colorado’s proposed ban on using public food assistance to pay for soft drinks, which already faced a tight approval timeline, is likely dead after a judge on Monday ruled the federal government la... |
| 02.09.2025 | Raya Therapeutic Announces Selection of one of its 5 compounds onto the EXPERTS-ALS Clinical Platform Trial | Company Logo
Positive data from this clinical study could lead to a registration trial of the compound for the treatment of ALS/MND.
MONTREAL, QUEBEC, CANADA, September 2, 2025 /EINPresswire.com/ -- Raya Therapeutic Inc., (“Raya”) a mission... |
| 23.05.2025 | Billy Joel cancels all future shows due to brain disorder | It’s not known when or if Joel plans to perform again. His string of nixed shows currently extends through July 3, 2026, when he hoped to play a previously postponed gig.
The New York native announced in March he was suspending upcoming per... |
| 08.05.2025 | Raya Therapeutic Appoints Juan Carlos Gomez MD, MBA, Chief Medical Officer of Shionogi and Company to its Board | Company Logo
Dr. Gomez brings extensive neuroscience and orphan disease development experience to Raya as it plans multiple clinical trials in 2026.
MONTREAL, QUEBEC, CANADA, May 8, 2025 /EINPresswire.com/ -- Raya Therapeutic Inc., (“Raya”)... |
| 03.03.2025 | Raya Therapeutic Announces FDA and EMA Orphan Drug Designations for ALS with RT1978 (epertinib) | Company Logo
The orphan drug designations (ODDs) are from both the FDA & EMA and for the treatment of Amyotrophic Lateral Sclerosis (ALS).
MONTREAL, QUEBEC, CANADA, March 3, 2025 /EINPresswire.com/ -- Raya Therapeutic Inc., (“Raya”) a m... |
| 17.02.2025 | How Pediatric Neurologists Diagnose and Treat Neurological Disorders | Share
Tweet
Share
Share
Email
Pediatric neurology focuses on diagnosing and treating neurological disorders in children, from newborns to adolescents. These doctors address conditions like epilepsy, autism, and developmental delays. Early d... |
| 13.02.2025 | FreeOx Biotech Celebrates Landmark 2024 with Record Growth: New Hires, Groundbreaking Trial Selections, and Major Funding Milestones | FreeOx Biotech
Innovative Biotech Company Expands Executive Team with Three C-Suite Appointments and Advances Pipeline with Key Trial Evaluations
BARCELONA and PALO ALTO, Feb. 13, 2025 /PRNewswire-PRWeb/ -- FreeOx Biotech, a clinical-stage ... |
| 09.01.2025 | Raya Therapeutic Announces 9 Orphan Drug Designations Across its 5 Clinical Stage Compounds | Company Logo
The orphan drug designations (ODDs) are from both the FDA & EMA and for the treatment of Amyotrophic Lateral Sclerosis (ALS) & other neurodegenerative diseases.
MONTREAL, QUEBEC, CANADA, January 9, 2025 /EINPresswire.co... |
| 20.11.2024 | NIH Awards BioCircuit Technologies $3M to Expand Nerve Tape® | Nerve Tape® Sutureless Connector
Funding will extend the Nerve Tape product line and accelerate clinical adoption.
ATLANTA, Nov. 20, 2024 /PRNewswire-PRWeb/ -- Medical device company BioCircuit Technologies has received a prestigious fundin... |
| 15.11.2024 | FreeOx's Ox-01 to be Evaluated as Adjunct Mechanical Thrombectomy Therapy for Stroke in NINDS-Funded Phase 2/3 Clinical Trial on Stroke-dedicated STEP Platform | FreeOx Biotech
FreeOx's Ox-01 Outperforms 3 Candidates from Big Pharma; Phase 2/3 Expected to Initiate in 2025
BARCELONA / PALO ALTO, Spain, Nov. 15, 2024 /PRNewswire-PRWeb/ -- FreeOx Biotech, a clinical stage biopharmaceutical company pion... |
| 13.11.2024 | Trace Neuroscience: A New Dawn in Genomic Medicine for ALS | In the realm of biopharmaceuticals, a new player has emerged, armed with ambition and a hefty $101 million in Series A funding. Trace Neuroscience is on a mission to reshape the landscape of genomic medicine, particularly for those grapplin... |
| 13.11.2024 | Trace Neuroscience: $101 Million (Series A) Raised To Expand Genomic Medicine Platform | Trace Neuroscience – a biopharmaceutical company expanding the promise of genomic medicine for people living with neurodegenerative diseases – announced its launch with a $101 million Series A funding led by Third Rock Ventures, with partic... |
| 17.10.2024 | Houston: A New Frontier for Remote Workers and Healthcare Innovations | Houston is emerging as a beacon for remote workers and a hub for healthcare advancements. Recent studies highlight its affordability and resources, while institutions like UTHealth are making strides in patient care. Houston is not just a c... |
| 15.10.2024 | Houston health care leader secures funding, milestones for latest initiatives across cancer, stroke, and more | UTHealth Houston is making waves in many disciplines right now. From cancer to Alzheimer’s disease to stroke, the institution is improving outcomes for patients in new ways. Last week, UTHealth announced three exciting updates to its roster... |
| 04.10.2024 | Managing Chronic Pain with Upper Cervical Chiropractic Care | Share
Tweet
Share
Share
Email
Chronic pain can impact day-to-day life, whether it’s from persistent back pain, neck discomfort, or other chronic conditions; living with constant pain can make everyday tasks challenging and reduce your overa... |
| 20.09.2024 | Neurexis Therapeutics: A $3 Million Leap Towards Neuroprotection | In the heart of Aurora, Colorado, a biopharmaceutical company is poised to change the landscape of neuroprotection. Neurexis Therapeutics has secured a $3 million grant from the National Institutes of Health (NIH). This funding, part of the... |
| 19.09.2024 | Pfizer introduces a new breakthrough for acute migraine relief in the UAE, aiming to transform patient care | Pfizer launching a new breakthrough for acute migraine treatment
Pfizer's new nasal spray breakthrough for acute migraine
Groundbreaking nasal spray treatment providing pain relief as early as 15 minutes. New treatment builds on Pfizer’s mi... |
| 18.09.2024 | Neurexis Therapeutics Secures $3 Million NIH Grant to Advance Neuroprotective Treatment for Global Cerebral Ischemia | Neurexis Therapeutics
A promising approach for preventing cognitive and behavioral impairment following ischemia
AURORA, Colo., Sept. 18, 2024 /PRNewswire-PRWeb/ -- Neurexis Therapeutics, a leading biopharmaceutical company focused on devel... |
| 17.09.2024 | RevBio: $2.4 Million NIH Grant Awarded From NINDS | RevBio announced that it was awarded a $2.4 million Phase II Small Business Innovation Research (SBIR) grant from the National Institute of Neurological Disease and Stroke (NINDS), which is part of the National Institutes of Health (NIH).
T... |
| 30.07.2024 | Children's Hospital of Philadelphia Researchers Use AI-Powered Method to Identify Genetic Epilepsies Much Earlier than Genetic Diagnosis | A new framework, confirmed in a study of 89 million points of data, could help patients receive precision care years earlier than before
PHILADELPHIA, July 30, 2024 /PRNewswire/ -- Diagnosing the genetic cause of a disease can aid in findin... |
| 26.07.2024 | The Olympic Stage: A Tale of Triumph and Turmoil**
** | ** The Olympic Games are a grand spectacle. They showcase human achievement, athletic prowess, and cultural unity. Yet, beneath the glittering surface, shadows lurk. Recent events have cast a pall over the upcoming Paris Games, highlighting... |
| 24.07.2024 | Olympics | Olympics opening ceremony: Will Celine Dion make a comeback? | Dion said earlier this year she vowed to return to the stage and her Las Vegas residency, though her sister said the 56-year-old singer’s symptoms can be “impossible to control.”
“Trying to overcome this autoimmune disorder has been one of ... |
| 26.06.2024 | What is POTS? Postural Orthostatic Tachycardia Syndrome, explained. | Christina Applegate's daughter Sadie recently revealed she was diagnosed with Postural Orthostatic Tachycardia Syndrome, or POTS, prompting questions about the condition.
POTS causes your heart to beat faster than normal when you go from si... |
| 20.06.2024 | Health | A sizzling summer may be even more painful for migraine sufferers | The study, produced by Teva Pharmaceuticals USA, tested the efficacy of a new preventive treatment on headaches caused by rising temperatures by cross-referencing regional weather data with 71,030 daily diary records of 6,060 migraine patie... |
| 04.06.2024 | 5-Minute Test Leads to Better Care for People with Dementia in the Primary Care Setting | BRONX, N.Y., June 4, 2024 /PRNewswire/ -- The underdiagnosis of dementia, especially among Black and Hispanic patients, is a long-standing challenge in medicine. A new study, published today in Nature Medicine, finds that an easy, five-minu... |
| 20.05.2024 | Knowing the Signs of Stroke | (Family Features) Stroke can happen to anyone – it happens to more than 800,000 people every year in the United States. Knowing the signs of stroke and how to prevent it can help protect you or your loved ones from disabilities caused by st... |
| 21.03.2024 | FDA Approves Nonsteroidal Treatment for Duchenne Muscular Dystrophy | For Immediate Release: March 21, 2024
Today, the U.S. Food and Drug Administration approved Duvyzat (givinostat) oral medication for the treatment of Duchenne Muscular Dystrophy (DMD) in patients six years of age and older. Duvyzat is the f... |
| 18.03.2024 | Dr. Dre said he ignored the symptoms of a brain aneurysm that almost killed him, and called high blood pressure a 'silent killer' | Entertainment Dr. Dre said he ignored the symptoms of a brain aneurysm that almost killed him, and called high blood pressure a 'silent killer'
Eammon Jacobs
2024-03-18T12:25:36Z
Share icon An curved arrow pointing right.
Share
Facebook Ico... |
| 18.03.2024 | Gene Therapy Is Now First FDA-Approved Treatment for Rare & Fatal CNS Disorder | A genetic medicine at the heart of a $387 million Kyowa Kirin acquisition has won FDA approval, a regulatory decision that makes the one-time treatment the first approved therapy for the rare inherited disorder metachromatic leukodystrophy ... |
| 24.01.2024 | Ireland Secures Access to World's Costliest Drug, Bringing Hope to Children Battling Rare Disease | John Lopez, Tech Times 24 January 2024, 07:01 am |
| 12.01.2024 | Health | Patients with narcolepsy face a dual nightmare of medication shortages and stigma | Lauren Peace, Tampa Bay Times | (TNS) KFF Health News
Nina Shand couldn’t stay awake.
She had taken afternoon naps since she was a teenager to accommodate her “work hard, play hard” attitude, but when she was in her mid-20s the sleepiness b... |
| 09.01.2024 | Meet the 23-year-old who's spreading awareness about ALS on TikTok and openly joking about being in her 'terminally ill era' | Culture Meet the 23-year-old who's spreading awareness about ALS on TikTok and openly joking about being in her 'terminally ill era'
Kieran Press-Reynolds
2024-01-08T21:15:41Z
Share icon An curved arrow pointing right.
Share
Facebook Icon T... |
| 18.12.2023 | ‘We’ve exhausted all avenues’: A small biotech may give up on its ultra-rare disease drug over frustration with FDA | Jamie Dubuque faces the future with a mixture of gratitude and trepidation.
Her son, Declan, who turns 2 years old in January, survived a life-threatening episode of cardiac arrest that sent him to a hospital emergency room a year ago. But ... |
| 06.12.2023 | Koselugo now available in Malaysia for paediatric patients with symptomatic neurofibromatosis type 1 (NF1) plexiform neurofibromas | KUALA LUMPUR, Malaysia, Dec. 6, 2023 /PRNewswire/ -- AstraZeneca's Koselugo (selumetinib) is now available in Malaysia as a monotherapy for the treatment of paediatric patients three years of age and older with neurofibromatosis type 1 (NF1... |
| 29.11.2023 | Time to take a nap? Sleep scientists say a midday rest is great for your health | Listen to this article
Time to take a nap? Sleep scientists say a midday rest is great for your health
1 min
New: You can now listen to articles.
Sorry, the audio is unavailable right now. Please try again later.
This audio is generated by ... |
| 27.11.2023 | Health | Babies are losing their lives to a preventable illness. Her job is stopping it | Emily Alpert Reyes | (TNS) Los Angeles Times
LOS ANGELES — Under the afternoon sun, Maggie Tran stopped one person after another on a hectic stretch of Skid Row, asking if they knew a particular woman.
No one seemed to recognize the name sh... |
| 26.11.2023 | Fighting the good fight against ALS | The first time "Sunday Morning" met Brian Wallach, in 2021, we feared it might be our last. He was already four years into a diagnosis of amyotrophic lateral sclerosis (or ALS), a rare and incurable disease that on average takes p... |
| 27.10.2023 | CMS changes coverage policy for carotid stenting to make it more widely available
What is different about the new CMS coverage determination for carotid stenting?
Hospitals performing carotid stenti... | Dave Fornell | October 18, 2023 | Cardiovascular Business | Interventional Cardiology |
| 19.10.2023 | Michael J. Fox on how far Parkinson’s research has come: ‘We don’t want to be celebrated. We want to get things done’ | When Michael J. Fox was diagnosed with Parkinson’s disease at age 29, his clearest symptom was a small one — his pinky finger was twitching. But even by that stage, 70% to 80% of a patient’s dopamine-producing cells are already gone, Fox sa... |
| 29.09.2023 | AI-driven data analysis could exacerbate misaligned incentives in biomedical research | This summer OpenAI released Code Interpreter, a plug-in for the popular ChatGPT tool that allows it to take in datasets, write and run Python code, and “create charts, edit files, perform math, etc.“ It aims to be nothing short of the ideal... |
| 08.08.2023 | What is ALS? Experts explain symptoms to look out for, causes and treatments | Sandra Bullock's longtime partner Bryan Randall died at age 57 after privately battling ALS, or Amyotrophic Lateral Sclerosis, for three years, his family said. The news brought new attention to the disease and prompted questions about what... |
| 19.07.2023 | Here’s Why Novartis Is Paying $500M to Acquire a Preclinical RNA Startup | Novartis has commercialized an RNA therapy that treats high cholesterol by hitting a target in the liver. By acquiring DTx Pharma, the Swiss pharmaceutical giant is betting the biotech can take its RNA research to more diseases in more part... |
| 13.07.2023 | What is Bell's palsy? What to know after Tiffany Chen's diagnosis reveal | The cause is a mystery — and the symptoms can be distressing. Bell's palsy comes on without warning, bringing partial paralysis or weakness to a person's face.
The condition affects thousands of people in the U.S. every year. And now Tiffan... |
| 10.07.2023 | A rare disease has run through five generations of his family, so he’s built community for others | For Jack Johnson, getting diagnosed with Fabry disease at age 7 was more of a formality. He’d been experiencing symptoms for several years already, and had watched multiple family members struggle with the rare condition. But around 7 was w... |
| 10.07.2023 | Why nearly half of Americans with Parkinson’s don’t see a neurologist | It took Richard Huckabee nine years to get a Parkinson’s diagnosis.
A district manager for a convenience store chain, he first noticed symptoms in 2004 when his voice would suddenly falter while speaking to large groups of employees. “It’s ... |
| 28.06.2023 | Health
Health | Grillo Center: How to get good quality sleep | Q: I know that sleep is important for my health, but how do I know if I’m getting enough sleep?
A: Sleep is a complex biological process that affects all systems of the body. Although you are unconscious during sleep, your brain and body fu... |
| 15.06.2023 | Singer Jesse Malin paralyzed from the waist down after suffering rare spinal cord stroke | Singer Jesse Malin revealed that he is paralyzed from the waist down after suffering a spinal cord stroke at a restaurant in New York City last month.
The 56-year-old punk rocker told Rolling Stone that he is currently wheelchair-bound and ... |
| 14.06.2023 | Synapse's 3D Model: This New Technique May Help Understand Neurodegenerative Diseases | Isaiah Richard, Tech Times 14 June 2023, 09:06 pm
Researchers have developed a 3D model of synapses, and it is a form of imaging that explores more how cells communicate with each other that have massive applications in the medical industry... |
| 28.05.2023 | Celine Dion cancels 2023 and 2024 shows as she battles rare disease | Celine Dion is battling Stiff-Person Syndrome. Image: Instagram | @celinedion
Canadian born singer, Celine Dion has cancelled all the remaining shows of her Courage World Tour for 2023 and 2024 due to ill health.
Dion apologised for disappo... |
| 26.05.2023 | Celine Dion cancels remaining dates of world tour due to health issues | Celine Dion has canceled the remaining dates of her world tour, which had already been postponed several times due to the pandemic and the singer's health issues.
"It is with tremendous disappointment that we have to announce today the... |
| 25.05.2023 | 10 common causes of body aches without a fever, and when to see a doctor | Reviews Chevron icon It indicates an expandable section or menu, or sometimes previous / next navigation options.
Health 10 common causes of body aches without a fever, and when to see a doctor
Written by Erin Heger
Updated
2023-05-24T22:03... |
| 22.05.2023 | I used to run a 5-minute mile. Developing Guillain-Barre syndrome impaired my mobility and changed my movement drastically. | Health I used to run a 5-minute mile. Developing Guillain-Barre syndrome impaired my mobility and changed my movement drastically.
Essay by Kelly Burch
2023-05-22T16:28:45Z
Share icon An curved arrow pointing right.
Share
Facebook Icon The ... |
| 17.05.2023 | ALLIANCE ORTHOPEDICS WELCOMES DR. VISHAL KHATRI, SPINE SURGEON SPECIALIZING IN COMPLEX AND MINIMALLY INVASIVE TECHNIQUES | Alliance Orthopedics is a leading provider of orthopedic care in Northern and Central New Jersey.
No two patients are the same, so I focus on an individualized, patient-centric treatment plan.”
— Dr. Vishal KhatriEAST BRUNSWICK, NEW JERSEY,... |
| 12.05.2023 | Michael J. Fox says he's suffered numerous injuries as a result of his Parkinson's | Michael J. Fox has suffered from a number of injuries as a result of his Parkinson's disease, which he was diagnosed with in 1991 at age 29, the actor revealed in an interview with Variety this week.
The 61-year-old "Back to the Future... |
| 25.04.2023 | Five Things The Mother Of A Blind Child Wishes More People Understood About The Condition | When Hilda Dunford learned that her baby boy, Ashton, would have to spend his life without sight, she was overwhelmed. "We got his diagnosis when he was just 2 months old and it was very hard," she says. Ashton, now age 11, was bo... |
| 24.04.2023 | What Is Parkinson's disease? Richard Lewis opens up about diagnosis | Comedian Richard Lewis revealed he's been diagnosed with Parkinson's disease.
In a video shared to Twitter Sunday, April 23, the "Curb Your Enthusiasm" star said a series of health complications have caused him to have "sort ... |
| 13.04.2023 | Céline Dion announces first new song since sharing about her neurological disorder | Superstar singer Céline Dion on Thursday announced the release of her latest single, "Love Again" — the first song she has put out since sharing publicly about her rare neurological disorder.
"Love Again" was made for th... |
| 04.04.2023 | When confronted with mysterious illness in college, ‘Chronically Catherine’ started writing | “Living With” explores the contours of life with chronic illness, from the prelude to diagnosis to new patterns of living, to wrestling with big questions about illness and health.
As Catherine Ames described it, this was quite a scene. She... |
| 03.04.2023 | What is Parkinson's disease? Neil Diamond opens up about his diagnosis | During an appearance on CBS "Sunday Morning," Neil Diamond opened up about living with Parkinson's disease.
The "Sweet Caroline" singer, 82, first revealed his diagnosis in January 2018, causing him to abruptly end his t... |
| 23.03.2023 | Biogen Provides Update on FDA Advisory Committee Meeting on Tofersen for SOD1-ALS | SOD1-ALS is a rare genetic form of the disease affecting approximately 330 people in the United States
/EIN News/ -- CAMBRIDGE, Mass., March 22, 2023 (GLOBE NEWSWIRE) -- Biogen Inc. (Nasdaq: BIIB) announced today the outcome of the U.S. Foo... |
| 23.03.2023 | Ionis accounces FDA advisory committee voted unanimously for a potential accelerated approval of tofersen for SOD1-ALS | If approved, tofersen will be the first treatment targeting a genetic cause of ALS and the next marketed Ionis-discovered antisense medicine FDA decision expected by April 25, 2023
CARLSBAD, Calif., March 22, 2023 /PRNewswire/ -- Ionis IONS... |
| 23.03.2023 | Health
Health | What is lead and what are the dangers of exposure? | Lead is a chemical element that has seen industrial and household use for hundreds of years, perhaps most famously by the Roman Empire as a sweetener for their wine, a pliable metal for plumbing, and a pigment in paint.
Lead was used in pai... |
| 01.03.2023 | Reata Pharma Drug Wins First FDA Nod in Ultra-Rare Neuromuscular Disorder | Friedrich’s ataxia, an ultra-rare disease characterized by progressively worsening muscle function that ultimately leads to death, now has its first FDA-approved therapy. The regulator has given the green light to a Reata Pharmaceuticals dr... |
| 28.02.2023 | FDA needs to build in more flexibility for rare disease clinical trials | My toddler, Wheeler, will probably not live to adulthood. Juvenile Batten disease — he has the type known as CLN3 — is stealing his childhood. And then this rare disease will steal my child.
Wheeler is missing the DNA needed to recycle a wa... |
| 22.02.2023 | 40% of employees in a 4-day work week trial reported fewer sleep issues | 40% of employees who participated in the UK's four-day work week trial reported fewer sleep issues.
Around 2,900 employees and 61 companies participated in the trial from June to December 2022.
Advertisement
The results are in from a large ... |
| 09.02.2023 | Christina Applegate says she's considering voiceover roles after her multiple sclerosis diagnosis to make sure her daughter is 'fed' and 'homed' | Entertainment Christina Applegate says she's considering voiceover roles after her multiple sclerosis diagnosis to make sure her daughter is 'fed' and 'homed'
Esme Mazzeo
2023-02-09T20:38:06Z
Share icon An curved arrow pointing right.
Share... |
| 09.01.2023 | Alterity Therapeutics Launches ATH434 Phase 2 Clinical Trial in the United States for the Treatment of Individuals with Multiple System Atrophy | U.S. now open for enrollment of rare, rapidly progressive Parkinsonian Disorder
MELBOURNE, Australia and SAN FRANCISCO, Jan. 9, 2023 /PRNewswire/ -- Alterity Therapeutics (ASX: ATH, NASDAQ: ATHE) ("Alterity" or "the Company&q... |
| 03.01.2023 | Rolling Stone listed the 200 greatest singers of all time. Celine Dion fans are outraged she didn't make the cut. | Rolling Stone magazine named the greatest singers of all time, and while 200 artists made the list, Celine Dion was not one of them — shocking fans and sparking outrage on social media.
Dion, a five-time Grammy winner who has had four No. 1... |
| 19.12.2022 | Celine Dion Diagnosed With Stiff-Person Syndrome | LONDON, ENGLAND - JULY 05: Celine Dion performs live on stage at Barclaycard Presents British ... [+] Summer Time Hyde Park at Hyde Park on July 05, 2019 in London, England. (Photo by Simone Joyner/Getty Images)Getty Images |
| 08.12.2022 | What is stiff-person syndrome, the disorder impacting Céline Dion's ability to sing? | Céline Dion revealed in an emotional and tear-filled announcement on Thursday that she had to postpone her upcoming European tour after being diagnosed with a "very rare neurological disorder": stiff-person syndrome.
The debilita... |
| 08.12.2022 | Céline Dion diagnosed with "very rare neurological disorder" that prevents her from singing normally | Singer Céline Dion announced that she is rescheduling her spring 2023 shows and canceling eight of her concerts planned for next summer after being diagnosed with a "very rare neurological disorder."
The 54-year-old French Canadi... |
| 28.11.2022 | Bionaut Labs gets $43.2M for its tiny drug delivery robots | Founded in 2017, Bionaut Labs arrived out of stealth in March 2021, with plans to commercialize longstanding research around drug delivery robots. The Los Angeles-based startup today followed up its initial $20 million funding announcement ... |
| 18.11.2022 | 'Dead To Me' showrunner says she told Christina Applegate her life was 'exponentially more important' than filming the final season after the actor received her MS diagnosis | Entertainment 'Dead To Me' showrunner says she told Christina Applegate her life was 'exponentially more important' than filming the final season after the actor received her MS diagnosis
Esme Mazzeo
2022-11-18T19:02:12Z
Share icon An curve... |
| 10.11.2022 | A man with ALS who can't use his hands got a brain implant that lets him text, shop online, and play games — just by thinking. It could be a game-changer. | Health A man with ALS who can't use his hands got a brain implant that lets him text, shop online, and play games — just by thinking. It could be a game-changer.
Hilary Brueck
2022-11-10T10:00:00Z
Share icon An curved arrow pointing right.
... |
| 07.11.2022 | Alterity Therapeutics Announces Presentation of Data from the bioMUSE Natural History Study at the American Autonomic Society Annual Meeting | MELBOURNE, Australia and SAN FRANCISCO, Nov. 7, 2022 /PRNewswire/ -- Alterity Therapeutics (ASX: ATH, NASDAQ: ATHE) ("Alterity" or "the Company"), a biotechnology company dedicated to developing disease modifying treatme... |
| 26.10.2022 | Alterity Therapeutics Announces Presentation of MRI Data from the bioMUSE Natural History Study at the American Neurological Association Annual Meeting | MELBOURNE, Australia and SAN FRANCISCO , Oct. 26, 2022 /PRNewswire/ -- Alterity Therapeutics (ASX: ATH, NASDAQ: ATHE) ("Alterity" or "the Company"), a biotechnology company dedicated to developing disease modifying treat... |
| 17.10.2022 | Managing Neuropathic Pain with Magnesium | Neuropathic pain is the type of pain you feel if your nervous system has been damaged and it can be very intense.
Alternative therapies such as meditation can help reduce the incidence and intensity of neuropathic pain.
A relaxing magnesium... |
| 13.10.2022 | Alterity Therapeutics Launches ATH434 Phase 2 Clinical Trial in Australia for the Treatment of Individuals with Multiple System Atrophy | Australia now open for study of rare, rapidly progressive Parkinsonian Disorder
MELBOURNE, Australia and SAN FRANCISCO, Oct. 13, 2022 /PRNewswire/ -- Alterity Therapeutics (ASX: ATH, NASDAQ: ATHE) ("Alterity" or "the Company&... |
| 05.10.2022 | No Rise in Guillain-Barre Syndrome Cases After COVID Shots: Study | WEDNESDAY, Oct. 5, 2022 (HealthDay News) -- A new study has found no evidence that COVID-19 shots increase the incidence of Guillain-Barré syndrome, according to researchers.
"This is important because we can say that there is no signi... |
| 01.10.2022 | FDA Approves New Treatment Option for Patients with ALS | For Immediate Release: September 29, 2022
The U.S. Food and Drug Administration today approved Relyvrio (sodium phenylbutyrate/taurursodiol) to treat patients with amyotrophic lateral sclerosis (ALS), commonly referred to as Lou Gehrig’s di... |
| 30.09.2022 | FDA Approves New ALS Drug Despite Uncertain Data
Was this page helpful? | FRIDAY, Sept. 30, 2022 (HealthDay News) – The U.S. Food and Drug Administration on Thursday gave its approval to a new drug for ALS (amyotrophic lateral sclerosis), also known as Lou Gehrig's disease.
But approval of the drug, called Relyvr... |
| 28.09.2022 | 6 FAQs about POTS, a debilitating chronic condition that many people develop after a bout of long COVID | Reviews Chevron icon It indicates an expandable section or menu, or sometimes previous / next navigation options.
Health 6 FAQs about POTS, a debilitating chronic condition that many people develop after a bout of long COVID
Written by Emil... |
| 26.09.2022 | Alterity Therapeutics Announces Presentation of Wearable Sensor Data from the bioMUSE Natural History Study at the International Congress of Parkinson's Disease and Movement Disorders | - Wearable sensors strongly correlated with clinical scales on motor impairment -
- bioMUSE Study Validates Use of Wearable Sensors for Alterity's Ongoing Phase 2 Clinical Trial -
MELBOURNE, Australia and SAN FRANCISCO, Sept. 26, 2022 /PRNe... |
| 23.09.2022 | Hints That Experimental Drug Might Curb a Form of ALS | FRIDAY, Sept. 23, 2022 (HealthDay News) -- People with a rare genetic form of ALS may benefit from extended use of an investigational drug, a new study shows.
The medication, tofersen, benefited patients with mutations of the gene SOD1. The... |
| 20.09.2022 | Alterity Therapeutics Receives U.S. FDA Approval for Investigational New Drug Application for ATH434 for the Treatment of Multiple System Atrophy | Regulatory Authorization Granted to Proceed with ATH434 Phase 2 Clinical Trial
MELBOURNE, Australia and SAN FRANCISCO, Sept. 20, 2022 /PRNewswire/ -- Alterity Therapeutics (ASX: ATH, NASDAQ: ATHE) ("Alterity" or "the Company&... |
| 12.09.2022 | Research Reveals Cause of 'Freezing' Gait in Parkinson's
Was this page helpful? | MONDAY, Sept. 12, 2022 (HealthDay News) -- Researchers think they've figured out why Parkinson's disease causes a person's limbs to become so stiff that at times they can feel frozen in place.
Using a robotic chair equipped with sensors, a ... |
| 08.09.2022 | In Rare Move, FDA Panel Gives Support to Controversial ALS Drug in 2nd Review
Was this page helpful? | THURSDAY, Sept. 8, 2022 (HealthDay News) – In a rare second review, a U.S. Food and Drug Administration panel on Wednesday recommended approval for an experimental drug for ALS (amyotrophic lateral sclerosis).
The FDA is not obligated to fo... |
| 06.09.2022 | FDA Panel Skeptical of Controversial ALS Drug Ahead of Vote
Was this page helpful? | TUESDAY, Sept. 6, 2022 (HealthDay News) – A U.S. Food and Drug Administration panel will once again consider approval for an experimental drug for ALS, a rare second review for a disease that has no cure.
The same panel that will meet Wedne... |
| 01.09.2022 | Understanding blood cancers, and how treatment advances offer hope | Blood cancer affects people across all ages and genders. However, awareness of the disease remains low due to its disparate nature.
“Many people think that there’s only one type of blood cancer; they are more aware of other common cancers s... |
| 25.08.2022 | Alterity Therapeutics Launches ATH434 Phase 2 Clinical Trial for the Treatment of Patients with Multiple System Atrophy in Europe | Second region now open for enrolment for rare, rapidly progressive, neurodegenerative disease
MELBOURNE, Australia and SAN FRANCISCO, Aug. 25, 2022 /PRNewswire/ -- Alterity Therapeutics (ASX: ATH, NASDAQ: ATHE) ("Alterity" or &quo... |
| 25.08.2022 | Ultomiris approved in Japan for gMG | Ultomiris approved in Japan for gMG
Thu, Aug 25, 2022 08:10 CET Report this content
25 August 2022 07:10 BST
Ultomiris approved in Japan for the treatment of adults with generalised myasthenia gravis
First and only long-acting C5 complement... |
| 18.08.2022 | Pregnancy Can Be Anxious Time for Women With Epilepsy
Was this page helpful? | THURSDAY, Aug. 18, 2022 (HealthDay News) -- Pregnant women with epilepsy battle anxiety and depression more often than their peers who aren't pregnant or don't have epilepsy, a new study reveals.
"The good news is we did not find that ... |
| 25.07.2022 | Ultomiris recommended for EU approval for gMG | Ultomiris recommended for EU approval for gMG
Mon, Jul 25, 2022 08:05 CET Report this content
25 July 07:05 BST
Ultomiris recommended for approval in the EU by CHMP for the treatment of adults with generalised myasthenia gravis
First and on... |
| 25.07.2022 | Ultomiris recommended for approval in the EU by CHMP for the treatment of adults with generalised myasthenia gravis | Ultomiris recommended for approval in the EU by CHMP for the treatment of adults with generalised myasthenia gravis
Mon, Jul 25, 2022 08:06 CET Report this content
First and only long-acting C5 complement inhibitor showed early effect and d... |
| 22.07.2022 | Alterity Therapeutics: Appendix 4C - Q4 FY22 Quarterly Cash Flow Report | Phase 2 clinical trial for ATH434 commences in New Zealand and patient enrolment begins
Regulatory approval from the U.K. and Italian regulatory agencies to proceed with the Phase 2 trial
A$4.1 million R&D Tax Incentive Scheme refund
Ca... |
| 07.07.2022 | Brad Pitt says he has face blindness. So what is prosopagnosia? | Brad Pitt says he believes he has prosopagnosia, a neurological disorder characterized by the inability to recognize faces. The condition, also known as "face blindness," can effect as many as 1 in 50 people, according to Faceblin... |
| 06.07.2022 | Alterity Therapeutics Doses First Patient in ATH434 Phase 2 Clinical Trial in Multiple System Atrophy | MELBOURNE, Australia and SAN FRANCISCO, July 6, 2022 /PRNewswire/ -- Alterity Therapeutics (ASX: ATH, NASDAQ: ATHE) ("Alterity" or "the Company"), a biotechnology company dedicated to developing disease modifying treatme... |
